BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 171822)

  • 1. Hepatic drug metabolism and adverse hepatic drug reactions.
    Schaffner F
    Vet Pathol; 1975; 12(2):145-56. PubMed ID: 171822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbon tetrachloride hepatotoxicity: an example of lethal cleavage.
    Rechnagel RO; Glende EA
    CRC Crit Rev Toxicol; 1973 Nov; 2(3):263-97. PubMed ID: 4357489
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug control of steroid metabolism by the hepatic endoplasmic reticulum.
    Feuer G
    Drug Metab Rev; 1983; 14(6):1119-44. PubMed ID: 6373207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute structural hepatic alteration due to poisons.
    Thaler H
    Acta Pharmacol Toxicol (Copenh); 1977; 41 Suppl 2():253-61. PubMed ID: 302572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic reactions to drugs.
    Sherlock S
    Gut; 1979 Jul; 20(7):634-48. PubMed ID: 488760
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-induced chronic hepatitis and cirrhosis.
    Maddrey WC; Boitnott JK
    Prog Liver Dis; 1979; 6():595-603. PubMed ID: 396573
    [No Abstract]   [Full Text] [Related]  

  • 7. Reactive metabolites as a cause of hepatotoxicity.
    Prescott LF
    Int J Clin Pharmacol Res; 1983; 3(6):437-41. PubMed ID: 6381340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preventive effect of riboflavin 2',3',4',5'-tetrabutyrate on inactivation of rat liver microsomal enzymes induced by carbon tetrachloride.
    Matsuoka S; Tahara K; Oama H
    J Nutr Sci Vitaminol (Tokyo); 1974; 20(4):333-6. PubMed ID: 4373553
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipid metabolites of carbon tetrachloride.
    Gordis E
    J Clin Invest; 1969 Jan; 48(1):203-9. PubMed ID: 5765023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug damage to the liver: role of reactive metabolites and pharmacokinetics].
    Lauterburg BH
    Schweiz Med Wochenschr; 1985 Sep; 115(38):1306-12. PubMed ID: 3933110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver parenchymal cell injury. VII. Membrane denaturation following carbon tetrachloride.
    Reynolds ES; Ree HJ
    Lab Invest; 1971 Sep; 25(3):269-78. PubMed ID: 4106225
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of medroxyprogesterone acetate on hepatic glucose metabolism and microsomal enzyme activity in rats with normal and altered liver.
    Stengård JH; Saarni HU; Sotaniemi EA
    Pharmacology; 1984; 28(1):34-41. PubMed ID: 6322213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug-induced liver damage; new aspects on its mechanism].
    Salaspuro M
    Duodecim; 1980; 96(5):394-402. PubMed ID: 6893817
    [No Abstract]   [Full Text] [Related]  

  • 14. Protection of hepatocytes with hyperoxia against carbon tetrachloride-induced injury.
    Bernacchi A; Myers R; Trump BF; Marzella L
    Toxicol Pathol; 1984; 12(4):315-23. PubMed ID: 6533753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical changes after hepatic injury from toxic doses of acetaminophen or furosemide.
    Thorgeirsson SS; Sasame HA; Mitchell JR; Jollow DJ; Potter WZ
    Pharmacology; 1976; 14(3):205-17. PubMed ID: 183224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rhythmicity in the structure-functional changes in hepatocytes following exposure to pesticides].
    Popov TA; Zadorozhnaia TD
    Biull Eksp Biol Med; 1977 Mar; 83(3):273-5. PubMed ID: 66948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and chronic drug-induced hepatitis.
    Pessayre D; Larrey D
    Baillieres Clin Gastroenterol; 1988 Apr; 2(2):385-422. PubMed ID: 3044468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interference of CCI4 metabolites with subcellular structures.
    Dianzani MU; Gabriel L; Gravela E; Paradisi L
    Panminerva Med; 1976; 18(9-10):310-9. PubMed ID: 980530
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of hepatoprotective agents containing phospholipids on cytochrome P-450-dependent antitoxic liver function during experimental toxic hepatitis].
    Saratikov AS; Vengerovskiĭ AI
    Biull Eksp Biol Med; 1999 Apr; 127(4):392-4. PubMed ID: 10367119
    [No Abstract]   [Full Text] [Related]  

  • 20. [Drug-induced hepatopathies].
    Kirchmayer S
    Pol Arch Med Wewn; 1974 May; 51(5):519-30. PubMed ID: 4832828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.